Browsing by Keyword : Anti-Asthmatic Agents
Showing results 1 to 14 of 14
| Pub Year | | Title | Author(s) |
| 2016 | | A Phase 2a Study of Benralizumab for Patients with Eosinophilic Asthma in South Korea and Japan | 박해심 |
| 2018 | | A Randomized, Multicenter, Double-blind, Phase III Study to Evaluate the Efficacy on Allergic Rhinitis and Safety of a Combination Therapy of Montelukast and Levocetirizine in Patients With Asthma and Allergic Rhinitis | 박해심 |
| 2019 | | Does Changing Inhaler Device Impact Real-Life Asthma Outcomes? Clinical and Economic Evaluation | 박해심 |
| 2021 | | Effect of omalizumab as add-on therapy to quality of life questionnaire for korean asthmatics (Kaqlq) in korean patients with severe persistent allergic asthma | 박해심 |
| 2022 | | Effectiveness of Maintenance and Reliever Therapy Using Inhaled Corticosteroid–Formoterol in Asthmatics | 박래웅, 박해심, 이영수, 장재혁 |
| 2021 | | Efficacy and safety of mepolizumab in korean patients with severe eosinophilic asthma from the dream and mensa studies | 박해심 |
| 2020 | | Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma | 박해심 |
| 2020 | | Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma | 박해심 |
| 2020 | | Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma | 박해심 |
| 2021 | | Engineering of Humanized Antibodies Against Human Interleukin 5 Receptor Alpha Subunit That Cause Potent Antibody-Dependent Cell-Mediated Cytotoxicity | 박해심, 정근옥, 최영우 |
| 2016 | | Leukotriene Receptor Antagonists for the Treatment of Asthma in Elderly Patients | 박해심, 반가영, 이지호 |
| 2021 | | Pragmatic Randomized Controlled Trial for Stepping Down Asthma Controller Treatment in Patients Controlled with Low-Dose Inhaled Corticosteroid and Long-Acting β2-Agonist: Step-Down of Intervention and Grade in Moderate Asthma Study | 신유섭 |
| 2015 | | Predictors of Asthma Control by Stepwise Treatment in Elderly Asthmatic Patients. | 박해심, 반가영, 예영민, 이윤환 |
| 2004 | | The HLA-DPB1*0301 marker might predict the requirement for leukotriene receptor antagonist in patients with aspirin-intolerant asthma. | 김승현, 박해심 |
1
